Grants and Contributions:
Title:
Automation of ONETest Next Gen Sequencing Assay Sample Preparation on Two Platforms
Agreement Number:
996893
Agreement Value:
$742,365.00
Agreement Date:
Aug 15, 2022 - Mar 31, 2025
Description:
This project will support the automation of the firm’s clinically validated, TRL-8 next generation sequencing-based pathogenomic assay for the detection of infectious disease on two different platforms – a microfluidic lab-on-a-chip device suitable for on-demand single patient testing, and a fluid handling robot, suitable for high throughput applications.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Richmond, British Columbia, CA V6V 0A3
Reference Number:
172-2022-2023-Q3-996893
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
828602243
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 50,000 dollars.
Amendment Date
Mar 6, 2025
Recipient's Operating Name:
Fusion Genomics
Recipient's Legal Name:
Fusion Genomics Corp.
Federal Riding Name:
Steveston--Richmond East
Federal Riding Number:
59031
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: